Literature DB >> 30010650

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia.

Travis B Nielsen1, Jun Yan2, Brian Luna2, Brad Spellberg3.   

Abstract

Murine infection models are critical for understanding disease pathogenesis and testing the efficacy of novel therapeutics designed to combat causative pathogens. Infectious pneumonia is among the most common infections presented by patients in the clinic and thus warrants an appropriate in vivo model. Typical pneumonia models use intranasal inoculation, which deposits excessive organisms outside the lung, causing off-target complications and symptoms, such as sinusitis, gastritis, enteritis, physical trauma, or microparticle misting to mimic aerosol spread more typical of viral, tuberculous, or fungal pneumonia. These models do not accurately reflect the pathogenesis of typical community- or healthcare-acquired bacterial pneumonia. In contrast, this murine model of oropharyngeal aspiration pneumonia mimics the droplet route in healthcare-acquired pneumonia. Inoculating 50 µL of the bacteria suspension into the oropharynx of anesthetized mice causes reflexive aspiration, which results in pneumonia. With this model, one can examine the pathogenesis of pneumonia-causing pathogens and new treatments to combat these diseases.

Entities:  

Mesh:

Year:  2018        PMID: 30010650      PMCID: PMC6102004          DOI: 10.3791/57672

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.

Authors:  Travis B Nielsen; Paul Pantapalangkoor; Brian M Luna; Kevin W Bruhn; Jun Yan; Ken Dekitani; Sarah Hsieh; Brandon Yeshoua; Bryan Pascual; Evgeny Vinogradov; Kristine M Hujer; T Nicholas Domitrovic; Robert A Bonomo; Thomas A Russo; Magda Lesczcyniecka; Thomas Schneider; Brad Spellberg
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

3.  Markers for predicting death as an outcome for mice used in infectious disease research.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

4.  Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry.

Authors:  Manira Rayamajhi; Elizabeth F Redente; Tracy V Condon; Mercedes Gonzalez-Juarrero; David W H Riches; Laurel L Lenz
Journal:  J Vis Exp       Date:  2011-05-02       Impact factor: 1.355

5.  Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.

Authors:  Darrin J Bast; M Yue; X Chen; D Bell; L Dresser; R Saskin; L A Mandell; D E Low; Joyce C S de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.

Authors:  E Azoulay-Dupuis; E Vallee; B Veber; J P Bedos; J Bauchet; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 7.  Animal models of human pneumonia.

Authors:  Joseph P Mizgerd; Shawn J Skerrett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

8.  Weight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infection.

Authors:  F Claire Hankenson; Nicholas Ruskoski; Marjorie van Saun; Gui-Shuang Ying; Jaewook Oh; Nigel W Fraser
Journal:  J Am Assoc Lab Anim Sci       Date:  2013       Impact factor: 1.232

9.  Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.

Authors:  Travis B Nielsen; Paul Pantapalangkoor; Jun Yan; Brian M Luna; Ken Dekitani; Kevin Bruhn; Brandon Tan; Justin Junus; Robert A Bonomo; Ann Marie Schmidt; Michael Everson; Frederick Duncanson; Terence M Doherty; Lin Lin; Brad Spellberg
Journal:  mBio       Date:  2017-08-22       Impact factor: 7.867

10.  Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies.

Authors:  Travis B Nielsen; Kevin W Bruhn; Paul Pantapalangkoor; Justin L Junus; Brad Spellberg
Journal:  BMC Microbiol       Date:  2015-11-02       Impact factor: 3.605

View more
  8 in total

Review 1.  FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.

Authors:  James M Byrne; Ursula Waack; Edward A Weinstein; Abhay Joshi; Simone M Shurland; Dmitri Iarikov; Jürgen B Bulitta; Binh An Diep; Tina Guina; William W Hope; Matthew B Lawrenz; Alexander J Lepak; Brian M Luna; Lynn Miesel; Andrew J Phipps; Thomas J Walsh; William Weiss; Thushi Amini; John J Farley
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  Murine Respiratory Tract Infection with Classical Klebsiella pneumoniae Induces Bronchus-Associated Lymphoid Tissue.

Authors:  Rachel K Wasbotten; Aubree A Dahler; Joseph J Mackel; Catherine Morffy Smith; David A Rosen
Journal:  Infect Immun       Date:  2022-03-21       Impact factor: 3.609

3.  lincRNA-Cox2 Functions to Regulate Inflammation in Alveolar Macrophages during Acute Lung Injury.

Authors:  Elektra Kantzari Robinson; Atesh Worthington; Donna Poscablo; Barbara Shapleigh; Mays Mohammed Salih; Haley Halasz; Lucas Seninge; Benny Mosqueira; Valeriya Smaliy; E Camilla Forsberg; Susan Carpenter
Journal:  J Immunol       Date:  2022-04-01       Impact factor: 5.426

4.  Evaluation of Nutritional Gel Supplementation in C57BL/6J Mice Infected with Mouse-Adapted Influenza A/PR/8/34 Virus.

Authors:  Jessica L Felgenhauer; Jourdan E Brune; Matthew E Long; Anne M Manicone; Mary Y Chang; Thea L Brabb; William A Altemeier; Charles W Frevert
Journal:  Comp Med       Date:  2020-12-01       Impact factor: 0.982

5.  Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii.

Authors:  Holly C May; Jieh-Juen Yu; Hao Zhang; Yufeng Wang; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  PLoS One       Date:  2019-07-02       Impact factor: 3.240

6.  Imaging of bioluminescent Klebsiella pneumoniae induced pulmonary infection in an immunosuppressed mouse model.

Authors:  Xing Hu; Yun Cai; Yuhang Wang; Rui Wang; Jin Wang; Bo Zhang
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

7.  Monoclonal Antibody Therapy against Acinetobacter baumannii.

Authors:  Travis B Nielsen; Jun Yan; Matthew Slarve; Peggy Lu; Rachel Li; Juan Ruiz; Bosul Lee; Elizabeth Burk; Yuli Talyansky; Peter Oelschlaeger; Kyle Hurth; William Win; Brian M Luna; Robert A Bonomo; Brad Spellberg
Journal:  Infect Immun       Date:  2021-07-26       Impact factor: 3.441

Review 8.  New Approach Methods to Evaluate Health Risks of Air Pollutants: Critical Design Considerations for In Vitro Exposure Testing.

Authors:  Jose Zavala; Anastasia N Freedman; John T Szilagyi; Ilona Jaspers; John F Wambaugh; Mark Higuchi; Julia E Rager
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.